157 related articles for article (PubMed ID: 33675985)
1. LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction.
Ma Y; Wang L; He F; Yang J; Ding Y; Ge S; Fan X; Zhou Y; Xu X; Jia R
Cancer Lett; 2021 May; 506():67-82. PubMed ID: 33675985
[TBL] [Abstract][Full Text] [Related]
2. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of LACTB, a Mitochondrial Protein That Inhibits Proliferation and Invasion in Glioma Cells.
Li HT; Dong DY; Liu Q; Xu YQ; Chen L
Oncol Res; 2019 Mar; 27(4):423-429. PubMed ID: 28835318
[TBL] [Abstract][Full Text] [Related]
4. Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.
Liu J; Yang L; Yuan X; Xiong M; Zhu J; Wu W; Ren M; Long J; Xu X; Gou M
Int J Nanomedicine; 2021; 16():7697-7709. PubMed ID: 34819728
[TBL] [Abstract][Full Text] [Related]
5. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.
Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW
J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415
[TBL] [Abstract][Full Text] [Related]
6. LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway.
Hu Y; Liu H; Zhu Z; Qi X; Yuan W; Tian M; Wang D; Xu J
Biochem Biophys Res Commun; 2022 Nov; 629():17-25. PubMed ID: 36088805
[TBL] [Abstract][Full Text] [Related]
7. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
8. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.
Peng LX; Wang MD; Xie P; Yang JP; Sun R; Zheng LS; Mei Y; Meng DF; Peng XS; Lang YH; Qiang YY; Li CZ; Xu L; Liu ZJ; Guo LL; Xie DH; Shu DT; Lin ST; Luo FF; Huang BJ; Qian CN
Cancer Lett; 2021 Feb; 498():165-177. PubMed ID: 33152401
[TBL] [Abstract][Full Text] [Related]
9. Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis.
Tan S; Zhao Z; Qiao Y; Zhang B; Zhang T; Zhang M; Qi J; Wang X; Meng M; Zhou Q
Biochem Pharmacol; 2021 Mar; 185():114423. PubMed ID: 33476574
[TBL] [Abstract][Full Text] [Related]
10. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.
Nguyen HB; Babcock JT; Wells CD; Quilliam LA
Oncogene; 2013 Aug; 32(35):4100-9. PubMed ID: 23027127
[TBL] [Abstract][Full Text] [Related]
11. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
12. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation.
McNeill H; Reginensi A
J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853
[TBL] [Abstract][Full Text] [Related]
13. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
Zhang X; Yang L; Szeto P; Abali GK; Zhang Y; Kulkarni A; Amarasinghe K; Li J; Vergara IA; Molania R; Papenfuss AT; McLean C; Shackleton M; Harvey KF
Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
[TBL] [Abstract][Full Text] [Related]
14. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
15. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
16. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
18. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
Sugihara T; Werneburg NW; Hernandez MC; Yang L; Kabashima A; Hirsova P; Yohanathan L; Sosa C; Truty MJ; Vasmatzis G; Gores GJ; Smoot RL
Mol Cancer Res; 2018 Oct; 16(10):1556-1567. PubMed ID: 29903769
[TBL] [Abstract][Full Text] [Related]
19. PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation.
Luo Y; Zhang Y; Pang S; Min J; Wang T; Wu D; Lin C; Xiao Z; Xiang Q; Li Q; Ma L
Mol Carcinog; 2023 Jul; 62(7):907-919. PubMed ID: 37157950
[TBL] [Abstract][Full Text] [Related]
20. LACTB exerts tumor suppressor properties in epithelial ovarian cancer through regulation of Slug.
Cutano V; Ferreira Mendes JM; Escudeiro-Lopes S; Machado S; Vinaixa Forner J; Gonzales-Morena JM; Prevorovsky M; Zemlianski V; Feng Y; Kralova Viziova P; Hartmanova A; Malcekova B; Jakoube P; Iyer S; Keckesova Z
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36375842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
